Table 1. Demographic and clinical characteristics for the entire study and stratified by drug.
IQR: interquartile range
| Total (n=64) | Risperidone (n=13) | Aripiprazole (n=10) | Clozapine (n=13) | Quetiapine (n=17) | Olanzapine (n=11) | |
| Age, years median (IQR) | 55.0 (46.0-60.0) | 59.0 (57.0-67.0) | 49.5 (45.0-56.0) | 54.0 (48.0-60.0) | 56.0 (47.0-59.0) | 50.0 (44.0-59.0) |
| Gender | ||||||
| Male | 35 (54.7) | 11 (84.6) | 2 (20.0) | 5 (38.5) | 9 (52.9) | 8 (72.7) |
| Female | 29 (45.3) | 2 (15.4) | 8 (80.0) | 8 (61.5) | 8 (47.1) | 3 (27.3) |
| Patient’s diagnosis | ||||||
| Bipolar | 11 (17.2) | 1 (7.7) | 3 (30.0) | 0 | 5 (29.4) | 2 (18.2) |
| Bipolar 2 | 3 (4.7) | 0 | 2 (20.0) | 0 | 0 | 1 (9.1) |
| Bipolar, depressed | 10 (15.6) | 1 (7.7) | 0 | 0 | 7 (41.2) | 2 (18.2) |
| Bipolar, mixed | 7 (10.9) | 2 (15.4) | 1 (10.0) | 0 | 3 (17.7) | 1 (9.1) |
| MDD | 1 (1.6) | 1 (1.7) | 0 | 0 | 0 | 0 |
| Schizoaffective | 19 (29.7) | 6 (46.2) | 3 (30.0) | 6 (46.2) | 2 (11.8) | 2 (18.2) |
| Schizophrenia | 13 (20.3) | 2 (15.4) | 1 (10.0) | 7 (53.9) | 0 | 3 (27.3) |